CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-12 | SAMAD SAM Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +17,403 | 17,403 | ||
| 2025-01-29 | SAMAD SAM Executive Vice President & CFO | Other acquisition | +35 | $158.04 | $6K | 17,539 |
| 2024-10-21 | SAMAD SAM Executive Vice President & CFO | Other acquisition | +37 | $149.37 | $6K | 17,504 |
| 2024-07-22 | SAMAD SAM Executive Vice President & CFO | Other acquisition | +21 | $146.97 | $3K | 17,467 |
| 2024-07-16 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −3,910 | $142.65 | $558K | 17,446 |
| 2024-04-22 | SAMAD SAM Executive Vice President & CFO | Grant or award | +24 | $126.25 | $3K | 21,356 |
| 2024-02-28 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −656 | $126.36 | $83K | 21,332 |
| 2024-02-14 | SAMAD SAM Executive Vice President & CFO | Grant or award | +5,478 | 21,988 | ||
| 2024-02-14 | SAMAD SAM Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +22,835 | 22,835 | ||
| 2024-01-31 | SAMAD SAM Executive Vice President & CFO | Grant or award | +17 | $129.33 | $2K | 16,510 |
| 2023-10-23 | SAMAD SAM Executive Vice President & CFO | Grant or award | +18 | $122.86 | $2K | 16,493 |
| 2023-07-14 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −3,909 | $140.18 | $548K | 16,475 |
| 2023-02-23 | SAMAD SAM Executive Vice President & CFO | Grant or award | +4,710 | 20,384 | ||
| 2023-02-23 | SAMAD SAM Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +18,616 | 18,616 |
Page 2 of 2 · 34 trades